Medherant's Series B Round

Medherant raised a round of funding on December 11, 2017. Investors include Mercia Technologies.

Medherant has been developing a technology to provide market ready drugs, such as painkillers, anti-infectives or hormone therapies, in the form of comfortable and easy-to-use patches. The company's c…

Articles about Medherant's Series B Round: